Literature DB >> 18041297

Surveillance of subtype and genetic variation of the circulating strains of HIV-1 in Thailand.

Piyanot Wirachsilp1, Wannee Kantakamalakul, Suporn Foongladda, Thippawan Chuenchitra, Surapol Kohriangudom, Niracha Athipanyasilp, Sombat Tanprasertsuk, Malee Gasitrong, Ruengpung Sutthent.   

Abstract

Two HIV-1 strains, CRF01_AE and subtype B', were reported in Thailand during the early years of the epidemic. Recently, an intersubtype recombination of HIV-1 strain was found in Thailand. Eight-hundred and twenty-eight samples collected during years 1995-2004 from high-risk groups in Bangkok, northern, northeastern, and southern region of Thailand were studied. HIV-1 env nucleotide sequences were used for phylogenetic analysis of the circulating HIV-1 strain. By single HIV-1 region (env) genotyping, CRFO1_AE was found in 97.3% and HIV-1 subtype B was found in 2.7%. A predominance of CRF01_AE was found in all geographic regions. Parallel analysis of the HIV-1 gag and env genes demonstrated that 2.1% and 4.0% of recombinant HIV-1 strains were found using p17 and p24 region sequences, respectively. The recombinant gag gene was also found in one southern isolate. Phylogenetic analysis of HIV-1 isolated from 20 provinces in 2002 suggested the northern and northeastern isolates were more related than the southern isolates which had the lowest genetic diversity of 0.13. The GPGQ V3 loop tip was also present in isolates from all regions. The molecular epidemiological data from this study may be useful for surveillance design as well as targeting prevention efforts. It also provides information regarding new antigenic regions of circulating strains responsible for the HIV-1 epidemic in Thailand.

Entities:  

Mesh:

Year:  2007        PMID: 18041297

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  8 in total

1.  Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia.

Authors:  Supachai Rerks-Ngarm; Punnee Pitisuttithum; Nirmal Ganguly; Linqi Zhang; Hiko Tamashiro; David A Cooper; Mean Chhi Vun; Budiman Bela; Rossana Ditangco; Nguyen Van Kinh; Alan Bernstein; Saladin Osmanov; Bonnie Mathieson; Stephen J Kent; Yiming Shao
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

2.  Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand.

Authors:  Jodi M Heaps; Pasiri Sithinamsuwan; Robert Paul; Sukalaya Lerdlum; Mantana Pothisri; David Clifford; Somporn Tipsuk; Stephanie Catella; Edgar Busovaca; James L K Fletcher; Benjamin Raudabaugh; Silvia Ratto-Kim; Victor Valcour; Jintanat Ananworanich
Journal:  J Neurovirol       Date:  2015-01-21       Impact factor: 2.643

3.  AIDS vaccine for Asia Network (AVAN): expanding the regional role in developing HIV vaccines.

Authors:  Stephen J Kent; David A Cooper; Mean Chhi Vun; Yiming Shao; Linqi Zhang; Nirmal Ganguly; Budiman Bela; Hiko Tamashiro; Rossana Ditangco; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Nguyen Van Kinh; Alan Bernstein; Saladin Osmanov
Journal:  PLoS Med       Date:  2010-09-21       Impact factor: 11.069

4.  Phylodynamics of HIV-1 from a phase III AIDS vaccine trial in Bangkok, Thailand.

Authors:  Marcos Pérez-Losada; David V Jobes; Faruk Sinangil; Keith A Crandall; Miguel Arenas; David Posada; Phillip W Berman
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

5.  A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais.

Authors:  Supranee Buranapraditkun; Ursula Hempel; Patrawadee Pitakpolrat; Rachel L Allgaier; Pattarawat Thantivorasit; Sven-Iver Lorenzen; Sunee Sirivichayakul; William H Hildebrand; Marcus Altfeld; Christian Brander; Bruce D Walker; Praphan Phanuphak; Pokrath Hansasuta; Sarah L Rowland-Jones; Todd M Allen; Kiat Ruxrungtham
Journal:  PLoS One       Date:  2011-08-22       Impact factor: 3.240

6.  Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand.

Authors:  Punnee Pitisuttithum; Supachai Rerks-Ngarm; Valai Bussaratid; Jittima Dhitavat; Wirach Maekanantawat; Swangjai Pungpak; Pravan Suntharasamai; Sirivan Vanijanonta; Sorachai Nitayapan; Jaranit Kaewkungwal; Michael Benenson; Patricia Morgan; Robert J O'Connell; Jeffrey Berenberg; Sanjay Gurunathan; Donald P Francis; Robert Paris; Joseph Chiu; Donald Stablein; Nelson L Michael; Jean-Louis Excler; Merlin L Robb; Jerome H Kim
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

7.  Field evaluation of Calypte's AWARE blood serum plasma (BSP) and oral mucosal transudate (OMT) rapid tests for detecting antibodies to HIV-1 and 2 in plasma and oral fluid.

Authors:  George A Alemnji; Gisele A Ngulefac; Peter M Ndumbe; Tazoacha Asonganyi
Journal:  Open AIDS J       Date:  2009-03-19

8.  HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

Authors:  Victor G Valcour; Jintanat Ananworanich; Melissa Agsalda; Napapon Sailasuta; Thep Chalermchai; Alexandra Schuetz; Cecilia Shikuma; Chin-Yuan Liang; Supunee Jirajariyavej; Pasiri Sithinamsuwan; Somporn Tipsuk; David B Clifford; Robert Paul; James L K Fletcher; Mary A Marovich; Bonnie M Slike; Victor DeGruttola; Bruce Shiramizu
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.